Cargando…
Prophylactic treatment of migraine; the patient's view, a qualitative study
BACKGROUND: Prophylactic treatment is an important but under-utilised option for the management of migraine. Patients and physicians appear to have reservations about initiating this treatment option. This paper explores the opinions, motives and expectations of patients regarding prophylactic migra...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3359207/ https://www.ncbi.nlm.nih.gov/pubmed/22405186 http://dx.doi.org/10.1186/1471-2296-13-13 |
_version_ | 1782233835504664576 |
---|---|
author | Dekker, Frans Knuistingh Neven, Arie Andriesse, Boukje Kernick, David Reis, Ria Ferrari, Michel D Assendelft, Willem JJ |
author_facet | Dekker, Frans Knuistingh Neven, Arie Andriesse, Boukje Kernick, David Reis, Ria Ferrari, Michel D Assendelft, Willem JJ |
author_sort | Dekker, Frans |
collection | PubMed |
description | BACKGROUND: Prophylactic treatment is an important but under-utilised option for the management of migraine. Patients and physicians appear to have reservations about initiating this treatment option. This paper explores the opinions, motives and expectations of patients regarding prophylactic migraine therapy. METHODS: A qualitative focus group study in general practice in the Netherlands with twenty patients recruited from urban and rural general practices. Three focus group meetings were held with 6-7 migraine patients per group (2 female and 1 male group). All participants were migraine patients according to the IHS (International Headache Society); 9 had experience with prophylactic medication. The focus group meetings were analysed using a general thematic analysis. RESULTS: For patients several distinguished factors count when making a decision on prophylactic treatment. The decision of a patient on prophylactic medication is depending on experience and perspectives, grouped into five categories, namely the context of being active or passive in taking the initiative to start prophylaxis; assessing the advantages and disadvantages of prophylaxis; satisfaction with current migraine treatment; the relationship with the physician and the feeling to be heard; and previous steps taken to prevent migraine. CONCLUSION: In addition to the functional impact of migraine, the decision to start prophylaxis is based on a complex of considerations from the patient's perspective (e.g. perceived burden of migraine, expected benefits or disadvantages, interaction with relatives, colleagues and physician). Therefore, when advising migraine patients about prophylaxis, their opinions should be taken into account. Patients need to be open to advice and information and intervention have to be offered at an appropriate moment in the course of migraine. |
format | Online Article Text |
id | pubmed-3359207 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-33592072012-05-24 Prophylactic treatment of migraine; the patient's view, a qualitative study Dekker, Frans Knuistingh Neven, Arie Andriesse, Boukje Kernick, David Reis, Ria Ferrari, Michel D Assendelft, Willem JJ BMC Fam Pract Research Article BACKGROUND: Prophylactic treatment is an important but under-utilised option for the management of migraine. Patients and physicians appear to have reservations about initiating this treatment option. This paper explores the opinions, motives and expectations of patients regarding prophylactic migraine therapy. METHODS: A qualitative focus group study in general practice in the Netherlands with twenty patients recruited from urban and rural general practices. Three focus group meetings were held with 6-7 migraine patients per group (2 female and 1 male group). All participants were migraine patients according to the IHS (International Headache Society); 9 had experience with prophylactic medication. The focus group meetings were analysed using a general thematic analysis. RESULTS: For patients several distinguished factors count when making a decision on prophylactic treatment. The decision of a patient on prophylactic medication is depending on experience and perspectives, grouped into five categories, namely the context of being active or passive in taking the initiative to start prophylaxis; assessing the advantages and disadvantages of prophylaxis; satisfaction with current migraine treatment; the relationship with the physician and the feeling to be heard; and previous steps taken to prevent migraine. CONCLUSION: In addition to the functional impact of migraine, the decision to start prophylaxis is based on a complex of considerations from the patient's perspective (e.g. perceived burden of migraine, expected benefits or disadvantages, interaction with relatives, colleagues and physician). Therefore, when advising migraine patients about prophylaxis, their opinions should be taken into account. Patients need to be open to advice and information and intervention have to be offered at an appropriate moment in the course of migraine. BioMed Central 2012-03-09 /pmc/articles/PMC3359207/ /pubmed/22405186 http://dx.doi.org/10.1186/1471-2296-13-13 Text en Copyright ©2012 Dekker et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Dekker, Frans Knuistingh Neven, Arie Andriesse, Boukje Kernick, David Reis, Ria Ferrari, Michel D Assendelft, Willem JJ Prophylactic treatment of migraine; the patient's view, a qualitative study |
title | Prophylactic treatment of migraine; the patient's view, a qualitative study |
title_full | Prophylactic treatment of migraine; the patient's view, a qualitative study |
title_fullStr | Prophylactic treatment of migraine; the patient's view, a qualitative study |
title_full_unstemmed | Prophylactic treatment of migraine; the patient's view, a qualitative study |
title_short | Prophylactic treatment of migraine; the patient's view, a qualitative study |
title_sort | prophylactic treatment of migraine; the patient's view, a qualitative study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3359207/ https://www.ncbi.nlm.nih.gov/pubmed/22405186 http://dx.doi.org/10.1186/1471-2296-13-13 |
work_keys_str_mv | AT dekkerfrans prophylactictreatmentofmigrainethepatientsviewaqualitativestudy AT knuistinghnevenarie prophylactictreatmentofmigrainethepatientsviewaqualitativestudy AT andriesseboukje prophylactictreatmentofmigrainethepatientsviewaqualitativestudy AT kernickdavid prophylactictreatmentofmigrainethepatientsviewaqualitativestudy AT reisria prophylactictreatmentofmigrainethepatientsviewaqualitativestudy AT ferrarimicheld prophylactictreatmentofmigrainethepatientsviewaqualitativestudy AT assendelftwillemjj prophylactictreatmentofmigrainethepatientsviewaqualitativestudy |